Health Condition 1: null- HIV positive patients under routine monitoring care at ART centres
Conditions
Interventions
None listed
Sponsors
Medecins Sans Frontires India
Eligibility
Inclusion criteria
Inclusion criteria: 1 Registered ART/pre-ART patients with either a new or established diagnosis of HIV 2 Written consent
Exclusion criteria
Exclusion criteria: 1 Previous treatment for, or current diagnosis of symptomatic visceral leishmaniasis or PKDL
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Determine prevalence of asymptomatic VL cases in HIV cases registered at ART centres from highly VL endemic areas - Determine the rate of conversion of asymptomatic VL cases into symptomatic VL over a period of 18 months. Timepoint: - Determine prevalence of asymptomatic VL cases in HIV cases registered at ART centres from highly VL endemic areas - Determine the rate of conversion of asymptomatic VL cases into symptomatic VL over a period of 18 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| - To correlate results of rk39 ICT with qPCR in PLHIV. - To determine risk factors for progression of asymptomatic cases to symptomatic VL over a follow up period of 18 months in PLHIV. Timepoint: 18 months | — |
Countries
India
Contacts
Public ContactDr Sakib Burza
Medecins Sans Frontières
Outcome results
None listed